Contact Information
Company Information
Company
Heidelberg Pharma AG
Technologies
SendInBlue
Mobile Friendly
Joomla
Apache
Remote
Keywords
onkologie
adc
atac
amanitin
biotechnology research
adc technology
antibody-drug conjugates
cancer therapy
targeted therapy
atac technology
tumor resistance
oncology
clinical development
bioconjugation
biopharmaceuticals
solid tumors
hematological cancers
innovative drugs
drug development
toxins
drug delivery systems
payloads
cancer treatment
therapeutic candidates
bcma-atac
cd37-atac
psma-atac
gcc-adc
clinical trials
fda approval
orphan drug designation
preclinical studies
biomarkers
rna polymerase ii
apoptosis
immuno-oncology
therapeutic modalities
drug candidates
phase i trials
phase ii trials
molecular targets
toxicology studies
pharmacokinetics
biological activity
tumor microenvironment
receptor-targeted therapy
collaborative studies
biotechnology partnerships
drug efficacy
serine protease inhibitors
covid-19 treatment
clinical efficacy
preclinical trials
pharmaceutical research
hospital & health care
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans